Persistent lumps suggest the same area is being used too often
Step 5: Ongoing Support Regular follow-up appointments, dosage adjustments as needed, and direct messaging with your care team keep you on track throughout the program
This could mean lowering it if cravings resurface or spacing out injections to reduce costs while maintaining progress
Key points GLP-1 is a hormone that increases insulin release and prevents the release of too much glucagon, helping manage blood glucose levels in individuals with type 2 diabetes GLP-1 receptor agonists, such as liraglutide and semaglutide, effectively reduce blood glucose levels Semaglutide is more effective than liraglutide at reducing blood sugar levels Tirzepatide is a newer GLP-1 receptor agonist that also mimics the actions of another hormone called GIP, which can also reduce blood sugar levels A randomised controlled trial showed that tirzepatide led to more significant blood sugar reductions than semaglutide across three doses Tirzepatide may be more effective than semaglutide at higher doses, but this needs further investigation Liraglutide and semaglutide are available in the UK and the US, while tirzepatide is only available in the US but is likely to be approved in the UK soon
Both Rubino and other experts around the world have seen similar patterns when administering GLP-1 drugs in their clinics
About 38% are motivated by cost savings through dose stretching
